Lv1
60 积分 2024-09-12 加入
驱动基因阳性晚期非小细胞肺癌免疫治疗专家共识(2023版)
15小时前
已完结
1989P Efficacy and safety of fulzerasib in patients (pts) with KRAS G12C-mutant non-small cell lung cancer (NSCLC): Updated results from phase I/II studies
1个月前
已关闭
辅助生殖领域拮抗剂方案标准化应用专家共识
5个月前
已完结
二价HPV疫苗接种策略的卫生经济学评估：基于动态模型
6个月前
已完结
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
9个月前
已完结
皖公网安备34019202002308
